Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Pediatr Med Chir ; 31(2): 72-7, 2009.
Article in Italian | MEDLINE | ID: mdl-19642499

ABSTRACT

OBJECTIVES: To know the mother's frequency with TRAb (TSH receptor antibodies) positivity during pregnancy in the population afferent to Agostino Gemelli Hospital in the five years 2002-2007 and the itself antibodies's role determining fetal and neonatal symptoms. MATERIALS AND METHODS: We performed a prospective analysis with maternal and neonatal variables detection in 16 couples mother-newborn with TRAb positivity during the pregnancy. The method to dose neonatal TRAb is ELISA (enzyme linked immunosorbant assay). RESULTS: The prevalence of newborns of mothers with TRAb positivity during pregancy results 0.1 per thousand (16/16783). The prevalence of neonatal hyperthyroidism, clinical and biochemical, in the studied population results especially elevated equal to about 30% (5/16). The 5 newborns are born to mothers with Basedow disease with TRAb serum levels greater than TRAb levels of newborn without hyperthyroidism: 2 are showed the symptoms of clinical hyperthyroidism and 3 a transient biochemical hyperthirodism. 3 newborns with hyperthyroidism among 5 are born to mother undergo thyroidectomy with L-tiroxina teraphy during the pregnancy. Then the newborns of thyroidectomized mothers also many years before the pregnancy must be considered high risk of developing neonatal hyperthyroidism because of long-lasting persistence of mother's TRAb. The neonatal hyperthyroidism, clinical and biochemical, appears later in newborns of mothers using antithyroid drugs. The pharmacological treatment of neonatal hyperthyroidism was difficult to standardize and highly individualized. CONCLUSIONS: Although the neonatal hyperthyroidism is a very rare disease it is essential to apply specific protocol assistance, both during pregnancy and the neonatal period, in the presence of maternal TRAb positive for the risk of serious cardiovascular complications.


Subject(s)
Child of Impaired Parents , Fetal Diseases/blood , Graves Disease/blood , Immunoglobulins, Thyroid-Stimulating/blood , Adult , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay , Female , Fetal Diseases/etiology , Fetal Diseases/immunology , Graves Disease/complications , Graves Disease/drug therapy , Graves Disease/immunology , Graves Disease/surgery , Humans , Hyperthyroidism/blood , Hyperthyroidism/congenital , Infant, Newborn , Male , Predictive Value of Tests , Pregnancy , Prevalence , Prospective Studies , Thyroidectomy/adverse effects , Thyroxine/adverse effects , Thyroxine/therapeutic use
2.
J Pediatr Endocrinol Metab ; 20(4): 535-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17550218

ABSTRACT

BACKGROUND: About 1-2% of infants born to mothers with Graves' disease or Hashimoto's thyroiditis develop neonatal hyperthyroidism because of transplacental passage of IgG stimulating TSH receptors (TRAb). OBJECTIVE: To evaluate the effect of maternal total thyroidectomy on neonatal clinical course. METHODS: We describe two brothers born to a mother with Graves' disease, before and after total thyroidectomy. RESULTS: The first child showed persistent tachycardia, the presence of TRAb and a laboratory pattern of hyperthyroidism. Lugol's solution was started and then propylthiouracil was added. Digitalis, furosemide and diazepam were necessary for treatment of heart failure, hypertension and irritability. On the 70th day of life, hormone serum levels normalized and treatment was interrupted. TRAb normalized by the third month of life. The second infant was born 2 years after the mother underwent total thyroidectomy. In spite of a laboratory pattern of hyperthyroidism and positivity to TRAb, he showed only considerable weight loss, and no therapy was required. CONCLUSIONS: TRAb may persist after total thyroidectomy: clinical and instrumental follow-up of the newborn is recommended.


Subject(s)
Child of Impaired Parents , Graves Disease/surgery , Hyperthyroidism/congenital , Pregnancy Complications/drug therapy , Siblings , Thyroidectomy , Female , Graves Disease/blood , Graves Disease/drug therapy , Humans , Hyperthyroidism/blood , Immunoglobulins, Thyroid-Stimulating/blood , Infant, Newborn , Iodides/therapeutic use , Male , Outcome Assessment, Health Care , Pregnancy , Thyroidectomy/adverse effects , Time Factors
3.
Pediatr Med Chir ; 29(2): 69-83, 2007.
Article in Italian | MEDLINE | ID: mdl-17461094

ABSTRACT

Many studies have recently analyzed the modulation of the intestinal microflora showing a benefic effects reducing the number of enteritis, improving the oligoelements absorption and stimulating the immunitary system. To do so three way are available: the use of prebiotics, the use of probiotics and the symbiotic way. Prebiotics are non-digestible oligosaccharides that can stimulate selectively the growth bifidogenus bacteria. Probiotics are dietary supplements made of live micro-organisms which improve the microbial environment of the gut. In this review literature is examined the possible efficacy of prebiotics and probiotics in the pediatric age; however, the studies available do not permit to obtain definitive conclusions.


Subject(s)
Dietary Supplements , Infant Nutritional Physiological Phenomena , Oligosaccharides/therapeutic use , Probiotics/therapeutic use , Adult , Age Factors , Case-Control Studies , Child , Child, Preschool , Clinical Trials as Topic , Dermatitis, Atopic/therapy , Diarrhea, Infantile/prevention & control , Humans , Infant , Infant Food , Intestines/microbiology , Milk, Human/chemistry , Nutritional Status , Nutritive Value , Oligosaccharides/analysis , Oligosaccharides/physiology , Probiotics/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL